AI brief of an SEC Form 8-K · Enovis (ENOV)

Enovis Q4 sales rise 23% to $561 million; impairment drives $704 million net loss

Mixed Impact 4 of 5 earnings Written later

Enovis reported fourth-quarter 2024 net sales of $561 million, up 23% on a reported basis, and adjusted earnings of $0.98 per diluted share, compared with $0.79 a year earlier. A $645 million non-cash goodwill impairment charge produced a fourth-quarter net loss from continuing operations of $704 million. The company also gave 2025 guidance of $2.19-2.22 billion in revenue and $3.10-3.25 in adjusted earnings per share, and CEO Matt Trerotola said he intends to retire once a successor is appointed.

Key points

  • Q4 2024 net sales $561 million, up 23% reported and 6% on a Comparable Sales basis
  • Q4 2024 net loss from continuing operations $704 million, including a $645 million goodwill impairment charge
  • Full-year 2024 net sales $2.1 billion, up 23%; full-year net loss from continuing operations $827 million
  • 2025 outlook: revenue $2.19-2.22 billion, adjusted EBITDA $405-415 million, adjusted EPS $3.10-3.25; CEO Matt Trerotola plans to retire upon successor appointment

The filing

CompanyEnovis (ENOV)
Form8-K, current report
Filed with the SECFeb 26, 2025, 6:11 AM ET
Accession number0001420800-25-000007

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:58 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 26, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.